CVS Health Corporation $CVS Stock Bought by Vise Technologies Inc.

Key Points

• Vise Technologies increased its CVS Health holdings by 27.7% in the third quarter, bringing its position to 75,195 shares valued at approximately $6.44 million. Institutional investors collectively own 80.66% of CVS shares.
• Analysts maintain a generally positive outlook, with 19 Buy ratings and three Holds, resulting in a “Moderate Buy” consensus and an average price target of $109.64.
• CVS reported quarterly earnings of $2.58 per share and revenue of $106.1 billion, both ahead of expectations. The company also declared a quarterly dividend of $0.665 per share, equivalent to a 3.0% annualized yield.

Vise Technologies Inc. increased its holdings in CVS Health Corporation (NYSE:CVS - Free Report) by 27.7% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 75,195 shares of the pharmacy operator's stock after buying an additional 16,303 shares during the period. Vise Technologies Inc.'s holdings in CVS Health were worth $6,443,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. BlackRock Inc. bought a new position in shares of CVS Health during the second quarter valued at approximately $12,747,462,000. State Street Corp raised its position in shares of CVS Health by 26.3% during the 2nd quarter. State Street Corp now owns 74,927,064 shares of the pharmacy operator's stock worth $7,751,205,000 after purchasing an additional 15,604,883 shares during the period. Wellington Management Group LLP lifted its holdings in shares of CVS Health by 49.8% in the 2nd quarter. Wellington Management Group LLP now owns 33,801,113 shares of the pharmacy operator's stock worth $3,496,725,000 after purchasing an additional 11,233,381 shares during the last quarter. Bank of America Corp DE lifted its holdings in shares of CVS Health by 148.0% in the 2nd quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator's stock worth $2,398,868,000 after purchasing an additional 13,836,701 shares during the last quarter. Finally, Pzena Investment Management LLC acquired a new position in CVS Health during the 2nd quarter valued at approximately $1,217,558,000. Institutional investors own 80.66% of the company's stock.

Analysts Set New Price Targets

Several brokerages have weighed in on CVS. Sanford C. Bernstein reaffirmed an "outperform" rating and issued a $112.00 target price on shares of CVS Health in a research report on Wednesday, September 9th. Wall Street Zen cut CVS Health from a "strong-buy" rating to a "buy" rating in a research note on Monday, October 19th. UBS Group reissued a "buy" rating on shares of CVS Health in a report on Tuesday, September 22nd. Wells Fargo & Company upped their price target on shares of CVS Health from $103.00 to $123.00 and gave the stock an "overweight" rating in a research report on Monday, July 13th. Finally, Robert W. Baird set a $107.00 price objective on shares of CVS Health in a report on Thursday, August 6th. Nineteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to MarketBeat.com, CVS Health has a consensus rating of "Moderate Buy" and a consensus price target of $109.64.

CVS Health Trading Down 1.9%

Shares of NYSE:CVS opened at $88.54 on Tuesday. The company has a 50 day moving average of $91.13 and a 200-day moving average of $88.80. The firm has a market cap of $113.24 billion, a P/E ratio of 23.42, a P/E/G ratio of 0.84 and a beta of 0.60. CVS Health Corporation has a twelve month low of $69.51 and a twelve month high of $110.68. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.74.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, beating analysts' consensus estimates of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The business had revenue of $106.10 billion for the quarter, compared to analyst estimates of $100.03 billion. During the same quarter last year, the business earned $1.81 earnings per share. The business's revenue for the quarter was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, analysts anticipate that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, November 2nd. Shareholders of record on Thursday, October 22nd were given a $0.6650 dividend. The ex-dividend date was Thursday, October 22nd. This represents a $2.66 annualized dividend and a yield of 3.0%. CVS Health's payout ratio is 70.37%.

CVS Health Company Profile

CVS Health Corporation NYSE: CVS is a diversified health care company that provides pharmacy, insurance and health services in the United States. Its businesses serve consumers, employers, health plans and health care providers through pharmacies, benefit programs, insurance coverage and clinical care services.

The company's Pharmacy Services segment, led by CVS Caremark, manages prescription drug benefits for employers, insurers and government programs. CVS Pharmacy operates retail pharmacies and health-focused stores that dispense prescriptions and offer over-the-counter products, health and wellness merchandise, immunizations and related services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.